NDC 59651-166 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 133 mg/1; Tenofovir Disoproxil Fumarate 200 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC59651-166

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Aurobindo Pharma Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA211640
Marketed since
March 9, 2023
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
59651-166-3030 TABLET, FILM COATED in 1 BOTTLE (59651-166-30)Mar 9, 2023

Other Emtricitabine and tenofovir disoproxil fumarate products